Baseline characteristics and risk of death on study
. | Died on study, N = 7 . | Did not die on study, N = 28 . | P . |
---|---|---|---|
Performance Score (%) | .0268 | ||
0 | 0 (0) | 10 (35.7) | |
1 | 2 (28.6) | 12 (42.9) | |
2 | 5 (71.4) | 6 (21.4) | |
Organs involved (%) | .7928 | ||
1 | 2 (28.6) | 15 (54) | |
2 | 2 (28.6) | 7 (25) | |
3 | 2 (28.6) | 5 (18) | |
4 | 1 (14.3) | 1 (4) | |
6 | 0 (0) | 1 (4) | |
Heart (%) | 7 (100) | 15 (53.6) | .0230 |
Kidney (%) | 4 (57.1) | 23 (82.1) | .1589 |
Liver (%) | 1 (14.3) | 4 (14.3) | 1.0000 |
New York Heart Class (%) | .0424 | ||
1 | 1 (14.3) | 16 (57.1) | |
2 | 6 (85.7) | 12 (42.9) | |
Serum troponin (ng/mL) | 0.1 (0.0-0.2) | 0.0 (0.0-0.2) | .0415 |
BNP value (pg/mL) | 1069.0 (284.0-2682.0) | 228.0 (17.0-1772.0) | .0119 |
NT-proBNP (pg/mL) | 11 228.0 (1285.0-15 675.0) | 988.0 (0.0-25926.0) | .0094 |
LVEF % | 60.0 (35.0-75.0) | 63.5 (40.0-75.0) | .1859 |
Creatinine | 1.2 (0.7-2.6) | 1.2 (0.5-2.8) | .7871 |
. | Died on study, N = 7 . | Did not die on study, N = 28 . | P . |
---|---|---|---|
Performance Score (%) | .0268 | ||
0 | 0 (0) | 10 (35.7) | |
1 | 2 (28.6) | 12 (42.9) | |
2 | 5 (71.4) | 6 (21.4) | |
Organs involved (%) | .7928 | ||
1 | 2 (28.6) | 15 (54) | |
2 | 2 (28.6) | 7 (25) | |
3 | 2 (28.6) | 5 (18) | |
4 | 1 (14.3) | 1 (4) | |
6 | 0 (0) | 1 (4) | |
Heart (%) | 7 (100) | 15 (53.6) | .0230 |
Kidney (%) | 4 (57.1) | 23 (82.1) | .1589 |
Liver (%) | 1 (14.3) | 4 (14.3) | 1.0000 |
New York Heart Class (%) | .0424 | ||
1 | 1 (14.3) | 16 (57.1) | |
2 | 6 (85.7) | 12 (42.9) | |
Serum troponin (ng/mL) | 0.1 (0.0-0.2) | 0.0 (0.0-0.2) | .0415 |
BNP value (pg/mL) | 1069.0 (284.0-2682.0) | 228.0 (17.0-1772.0) | .0119 |
NT-proBNP (pg/mL) | 11 228.0 (1285.0-15 675.0) | 988.0 (0.0-25926.0) | .0094 |
LVEF % | 60.0 (35.0-75.0) | 63.5 (40.0-75.0) | .1859 |
Creatinine | 1.2 (0.7-2.6) | 1.2 (0.5-2.8) | .7871 |
BNP indicates brain natriuretic peptide; and LVEF, left ventricular ejection fraction.